Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sarnelli

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
The Importance of Uncertainty Analysis and Traceable Measurements in Routine Quantitative <sup>90</sup>Y-PET Molecular Radiotherapy: A Multicenter ExperienceMarco D'Arienzo, Emilio Mezzenga, Amedeo Capotosti, et al.
Seminars in Nuclear Medicine|January 8, 2022
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative SettingFrancesco Cicone, Anna Sarnelli, Claretta Guidi, et al.
International Journal of Molecular Sciences|November 13, 2020
Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate CancerAlice Zamagni, Michele Zanoni, Michela Cortesi, et al.
DNA Repair|September 5, 2020
Effects of radiotherapy and short-term starvation combination on metastatic and non-tumor cell linesSara Pignatta, Michela Cortesi, Chiara Arienti, et al.
Molecular Imaging and Biology|November 24, 2019
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CTSerena Baiocco, Federica Matteucci, Emilio Mezzenga, et al.
Neuroendocrinology|February 9, 2013
Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumorsMaddalena Sansovini, Stefano Severi, Alice Ambrosetti, et al.
Cancers|April 23, 2022
Radiomics Analysis on [<sup>68</sup>Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE TrialGiacomo Feliciani, Monica Celli, Fabio Ferroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 29, 2024
Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neckGiacomo Feliciani, Tiziana Licciardello, Claretta Guidi, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical studyFrancesca Botta, Marta Cremonesi, Mahila E Ferrari, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
The Importance of Uncertainty Analysis and Traceable Measurements in Routine Quantitative <sup>90</sup>Y-PET Molecular Radiotherapy: A Multicenter ExperienceMarco D'Arienzo, Emilio Mezzenga, Amedeo Capotosti, et al.
Seminars in Nuclear Medicine|January 8, 2022
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative SettingFrancesco Cicone, Anna Sarnelli, Claretta Guidi, et al.
International Journal of Molecular Sciences|November 13, 2020
Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate CancerAlice Zamagni, Michele Zanoni, Michela Cortesi, et al.
DNA Repair|September 5, 2020
Effects of radiotherapy and short-term starvation combination on metastatic and non-tumor cell linesSara Pignatta, Michela Cortesi, Chiara Arienti, et al.
Molecular Imaging and Biology|November 24, 2019
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CTSerena Baiocco, Federica Matteucci, Emilio Mezzenga, et al.
Neuroendocrinology|February 9, 2013
Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumorsMaddalena Sansovini, Stefano Severi, Alice Ambrosetti, et al.
Cancers|April 23, 2022
Radiomics Analysis on [<sup>68</sup>Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE TrialGiacomo Feliciani, Monica Celli, Fabio Ferroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 29, 2024
Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neckGiacomo Feliciani, Tiziana Licciardello, Claretta Guidi, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical studyFrancesca Botta, Marta Cremonesi, Mahila E Ferrari, et al.
Pageof 7